News | Press Releases

---

September 16, 2009

TOSHIBA EXPANDS AVAILABILITY OF NEXT GENERATION ADVANCED IMAGE PROCESSING FOR INFINIX-i LINE

Next Generation AIP Improves Image Quality and Diagnostic Capabilities

TUSTIN, Calif., Sept. 16, 2009 —Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line. Toshiba will showcase Next Generation AIP at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).

“Next Generation AIP has made an immediate impact on patient care in facilities across the country, so we are expanding its availability to additional systems in the Infinix line,” said Robert Micer, director, X-ray Vascular Business Unit, Toshiba. “This new processor produces better image quality, reduces background noise, and improves device and vessel visualization to allow physicians to improve workflow and provide better patient care during interventional procedures.”

Toshiba’s Next Generation AIP feature improves patient care by increasing the quality, sharpness, and image contrast during interventional procedures. This proprietary technology has virtually eliminated image lag, benefiting clinicians while guiding and deploying devices during fluoroscopy. Next Generation AIP further increases image clarity during interventional procedures to create a safer, more time-efficient exam for the patient by reducing the possibility of having to re-image the patient if the image is not clear. Next Generation AIP is particularly beneficial for stent implementation, patients with rapid heart rates or small tortuous arteries, bariatric patients and emergency situations.

Next Generation AIP was evaluated by Dr. Vinit Lal, interventional cardiologist, HeartPlace, who noted the upgraded processor has increased accuracy and improved workflow and helped ensure excellent patient care.

“As the first in the country to work hands-on with Next Generation AIP, I have been extremely impressed with the images produced,” said Dr. Lal. “This upgraded processor is increasing workflow, patient throughput and cath lab utilization, all while providing a safer exam for the patient, which is exactly what is needed in today’s health care environment.”

Next Generation AIP is available now on the Infinix-i systems with mid-and large-sized flat panel detectors, optimizing imaging for cardiac, vascular and neuro procedures.

About Toshiba

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 198,000 employees worldwide and annual sales of $77 billion. For more information, visit www.medical.toshiba.com

.